Methods of treating cancer using a modified endostatin protein

Details Methods of treating cancer using a modified endostatin protein Methods of treating cancer using a modified endostatin protein

2005-04-29

2008-12-30

Monshipouri, Maryam (Department: 1656)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

07470667

ABSTRACT:
The present invention provides methods of treating an angiogenesis-related disease of a subject using a therapeutically effective amount of a modified endostatin protein. In particular, the methods encompass treating an angiogenesis-related disease of a subject using a combination of the modified endostatin, and a known cancer therapy agent such as a chemotherapy agent, or a radiotherapy agent.

REFERENCES:
patent: 6825167 (2004-11-01), Yokoyama et al.
patent: 6949514 (2005-09-01), Wallner et al.
patent: 00/26368 (2000-05-01), None

Affiliated with

Also associated with

Rating

Methods of treating cancer using a modified endostatin protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treating cancer using a modified endostatin protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating cancer using a modified endostatin protein will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4026397